Today: 10 June 2026
Critical Metals stock jumps again as Greenland takeover talk keeps rare-earth traders on edge
7 January 2026
1 min read

Critical Metals stock jumps again as Greenland takeover talk keeps rare-earth traders on edge

New York, Jan 7, 2026, 05:18 EST — Premarket

  • Critical Metals was up about 9% premarket after a 26% jump in the prior session.
  • Traders pointed to renewed U.S. talk of acquiring Greenland, where the company is developing its Tanbreez rare-earths project.
  • Investors are watching U.S. jobs data on Friday and any fresh signals from Washington on Greenland.

Critical Metals Corp shares were up 9.2% in premarket trading on Wednesday at $12.90, after closing up 25.6% in the prior session, as renewed U.S. rhetoric over acquiring Greenland stirred fresh interest in rare-earth names.

The move matters because Critical Metals’ flagship Tanbreez project sits in southern Greenland, and rare earths — a group of metals used in magnets for electric motors, electronics and defence systems — have become a strategic focus as the U.S. tries to diversify supply chains away from China.

It also lands as political risk returns to the Arctic. The White House said President Donald Trump was discussing options to acquire Greenland, including the possible use of the U.S. military, even as Greenland and Denmark have rejected any takeover.

Investors in small, project-stage miners often trade headlines that hint at funding, permitting and offtake — long-term contracts to sell future output — rather than near-term earnings. CEO Tony Sage told Reuters last week the company expects to finalise the remaining 25% of Tanbreez offtake agreements by early 2026 and would be open to a Washington investment: “Would welcome it, even though we didn’t ask for it,” he said. Reuters

The stock on Tuesday traded between $9.82 and $12.00, putting the $12 level back in view for short-term traders, after a steep run over the past year that has left the shares well below their 52-week high but far above their lows.

A U.S. peer, MP Materials, was last indicated around $59.82, up about 2% from its prior close, as investors rotated into parts of the critical-minerals space amid the Greenland headlines.

But the rally carries clear risks. Any shift in Greenland’s status remains highly uncertain, and the White House’s comments have already drawn pushback in Europe; a sharper diplomatic response — or a cooling of U.S. rhetoric — could drain the momentum that has driven the stock in recent sessions.

Stock Market Today

  • Copart (CPRT) Share Price Slump Raises Reassessment Questions Amid Undervaluation
    June 10, 2026, 8:50 AM EDT. Copart's share price has declined 37.7% over the past year, prompting investors to reassess its value. Recent trading closed at $31.31, a 1.5% rise over seven days but down 17.1% year to date. A Discounted Cash Flow (DCF) analysis estimates Copart's intrinsic value at $38.93, suggesting the stock is undervalued by approximately 19.6%. The DCF model, focusing on future free cash flow projections, indicates potential upside if cash flow assumptions hold. Copart trades at a Price-to-Earnings (P/E) ratio of 18.66, reflecting investor expectations on growth and risk. The prolonged multi-year price slump, coupled with evolving market perceptions in vehicle auction and salvage sectors, is driving fresh investor scrutiny on Copart's risk and growth potential.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Gold price nears record and lifts Newmont stock after hours — what investors watch next
Previous Story

Gold price nears record and lifts Newmont stock after hours — what investors watch next

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope
Next Story

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope

Go toTop